Alex1Powell's Categories
Alex1Powell's Authors
Latest Saves
The Question Has Always Been Innocence
What makes an innocent man plead guilty? There is a lie in America. The lie is that Judges, Courts, Prosecutors are honest. They prosecute for Justice, we're told. They do not.
Michael Flynn's criminal case is officially over, but Judge Sullivan makes very clear that a presidential pardon does not mean that Flynn is innocent of the crime he pleaded guilty to twice pic.twitter.com/K2VgvUnDuV
— Zoe Tillman (@ZoeTillman) December 8, 2020
Under Article III, US Supreme Court settles disputes between 2 or more states
Due to safe harbour, Trump’s remaining legal routes are narrow after
Brief analysis:
The Texas case is about the contested swing states’ executive & judicial branches VS their legislatures, on mail-in ballot rules
On Tuesday before safe harbour, SCOTUS rejected a similar lawsuit brought by Republican Rep. Mike Kelly
But a 3rd & eerily similar case has been with Justice Alito (as circuit judge for PA) & the Supreme Court since before the election. It’s about this very same executive & judiciary VS legislature dispute. That case, PA Republican Party vs Boockvar, may be decided in time, or not
A pending Supreme Court judgement in the case of Boockvar decides Pennsylvania
— Maajid \u0623\u0628\u0648 \u0639\u0645\u0651\u0627\u0631 (@MaajidNawaz) November 11, 2020
That was not a fraud case. The number of votes is secondary
It is about auditing a temporary mail ballot ringfence, imposed till a constitutional case against alleged judicial activism in PA is heard https://t.co/ek8gkDibKZ
The below is also worth noting:
It is important for election heads following this story to note that in Arizona, Pennsylvania, Minnesota and Georgia the electoral college is *not legally obliged* to vote as their state did. If disputes about election integrity continue, what these electors think, will matter
— Maajid \u0623\u0628\u0648 \u0639\u0645\u0651\u0627\u0631 (@MaajidNawaz) November 13, 2020
There is also the issue of ‘safe harbour’ being said to only be “procedural”. This view rests on a reading of the Bush v Gore Supreme Court ruling.
Watch along:
Just 15 mins until the launch event for our new advice to Government on the Sixth Carbon Budget. If you haven\u2019t registered, you can watch live on YouTube from 10am. Link: https://t.co/PjlcIDSYEC #UKCarbonBudget pic.twitter.com/1zOTfmxDVp
— Climate Change Committee (@theCCCuk) December 9, 2020
Will tweet along snippets. Pretty relevant to...............everything, really. #UKCarbonBudget
"Instead of being just a budget, it's a pathway we have to tread to reach net zero in 2050" @lorddeben
Just like quite a few other modelling exercises, CCC use a spectrum between behaviour change and between technological change. #UKCarbonBudget.
Both = best (just like @AEMO_Media's Step Change scenario in their ISP)
'Balanced' is what they use for their recs. "We're doing 60% of the emissions reductions in the first 15 years, and then 40% in the next".
The slinky kitty curve....good to see. No evidence of delaying action to Dec 29 2049, here. #UKCarbonBudget
"By front loading, we're minimising the UK's contribution to cumulative emissions" - really important point. A slow path to net zero - more climate harm than a fast one. #UKCarbonBudget
#quilt #quilting #sewing #fabric #textiles #thread #material #craft #crafters #sewing #sewers #quilters #talent #talented #stunning #color #beautiful
https://t.co/KoGl534siv
On leather!
https://t.co/kISvLeL83W
https://t.co/zsc2eBVI4e Tons of great preclinical work on TIE2 MOA showing clear correlation to SC integrity, adult-onset glaucoma, and disease-modifying effects. See mosaic if interested
can you share the preclinical work you describe along with the papers?
— James Brandt (@jmsbrandt) November 20, 2020
What do KOL's think of the new MOA: Special session held at ARVO 2019 to discuss Tie2 for Glaucoma. $ARPO then completed a closely watched P1b with a topical formulation. Now, a P2b trial in 195 pts enrolled within 3 mos, a month ahead of schedule, in the middle of a pandemic.
SOC is PG (-7 mm Hg IOP) +/- adjunct (-1 to -1.5 mm delta). Best efficacy adjunct is Rocklatan (-1.5), but AE profile: hyperemia (60 vs 15%), pruritus (8 vs 2%) site pain (20 vs 7%) vs PG , + other AE’s not seen with PG: 10% conjunctival hemorrhage, 15% verticillata. Almost DOA
But, sells $80 to $100M/yr US (same as $ARPO MC ha!). Every 0.3 mm reduction critical towards delaying vision loss. Rocklatan MOA was projected to make it a $1B drug, until AE profile (& payor delays) killed launch. $ARPO thesis: Raz efficacy >/= Rocklatan, without AE baggage.